PTEN down regulates AP-1 and targets c-fos in human glioma cells via PI3-kinase/Akt pathway (Q40181453)

18 September 2017

title

PTEN down regulates AP-1 and targets c-fos in human glioma cells via PI3-kinase/Akt pathway (English)

1 reference

18 September 2017

Dimpy Koul

1

1 reference

18 September 2017

Ruijun Shen

2

1 reference

18 September 2017

Shishir Shishodia

3

1 reference

18 September 2017

Yasanuri Takada

4

1 reference

18 September 2017

Krishna P Bhat

5

1 reference

18 September 2017

Shrikanth A G Reddy

6

1 reference

18 September 2017

Bharat B Aggarwal

7

1 reference

18 September 2017

W K Alfred Yung

8

1 reference

18 September 2017

publication date

18 January 2007

1 reference

Molecular and Cellular Biochemistry

18 September 2017

published in

1 reference

18 September 2017

volume

300

1 reference

18 September 2017

issue

1-2

1 reference

18 September 2017

page(s)

77-87

1 reference

Fra-1 induces morphological transformation and increases in vitro invasiveness and motility of epithelioid adenocarcinoma cells

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11010-006-9371-8

Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-006-9371-8

Requirement for phosphatidylinositol 3-kinase in epidermal growth factor-induced AP-1 transactivation and transformation in JB6 P+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-006-9371-8

Modification of fos proteins: phosphorylation of c-fos, but not v-fos, is stimulated by 12-tetradecanoyl-phorbol-13-acetate and serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-006-9371-8

Induction of apoptosis by c-Fos protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-006-9371-8

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

21 January 2018

1 reference

12 December 2020

Activation of nuclear factor of activated T cells-(NFAT) and activating protein 1 (AP-1) by oncogenic 70Z Cbl requires an intact phosphotyrosine binding domain but not Crk(L) or p85 phosphatidylinositol 3-kinase association

1 reference

12 December 2020

The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signaling

1 reference

12 December 2020

AP-1 in mouse development and tumorigenesis

1 reference

12 December 2020

Signalling through phosphoinositide 3-kinases: the lipids take centre stage

1 reference

12 December 2020

Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN

1 reference

12 December 2020

The lipid phosphatase activity of PTEN is critical for its tumor supressor function

1 reference

12 December 2020

AP-1: a double-edged sword in tumorigenesis

1 reference

12 December 2020

AKT inhibition is associated with chemosensitisation in the pancreatic cancer cell line MIA-PaCa-2

1 reference

12 December 2020

PIK3CA is implicated as an oncogene in ovarian cancer.

1 reference

12 December 2020

Immunocytochemical localization of fos protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy

1 reference

12 December 2020

c-fos proto-oncogene regulation and function

1 reference

12 December 2020

Tissue-targeted antisense c-fos retroviral vector inhibits established breast cancer xenografts in nude mice

1 reference

12 December 2020

The transcription factor AP-1 is required for EGF-induced activation of rho-like GTPases, cytoskeletal rearrangements, motility, and in vitro invasion of A431 cells.

1 reference

12 December 2020

PI-3' kinase and NF-kappaB cross-signaling in human pancreatic cancer cells

1 reference

12 December 2020

Astrocyte-specific expression of the alpha1-antichymotrypsin and glial fibrillary acidic protein genes requires activator protein-1.

1 reference

12 December 2020

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

1 reference

12 December 2020

Phosphatidylinositol 3-kinase as a mediator of TNF-induced NF-kappa B activation

1 reference

12 December 2020

Regulation of cell death protease caspase-9 by phosphorylation

1 reference

12 December 2020

Tumor suppressor MMAC/PTEN inhibits cytokine-induced NFkappaB activation without interfering with the IkappaB degradation pathway

1 reference

12 December 2020

Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery

1 reference

12 December 2020

New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway

1 reference

12 December 2020

Phosphatidylinositol-3 kinase is necessary for 12-O-tetradecanoylphorbol-13-acetate-induced cell transformation and activated protein 1 activation

1 reference

12 December 2020

Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity

1 reference

12 December 2020

Fos and Jun: the AP-1 connection

1 reference

12 December 2020

AP-1 in cell proliferation and survival

1 reference

12 December 2020

Phosphatidylinositol 3-kinase in interleukin 1 signaling. Physical interaction with the interleukin 1 receptor and requirement in NFkappaB and AP-1 activation

1 reference

12 December 2020

Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma

1 reference

12 December 2020

C-Fos is not essential for apoptosis.

1 reference

12 December 2020

Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase

1 reference

12 December 2020

FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells.

1 reference

12 December 2020

NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling

1 reference

12 December 2020

c-fos is required for malignant progression of skin tumors.

1 reference

12 December 2020

The conditional probability of survival of patients with primary malignant brain tumors: surveillance, epidemiology, and end results (SEER) data

1 reference

12 December 2020

Inducible production of c-fos antisense RNA inhibits 3T3 cell proliferation

1 reference

12 December 2020

Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor

1 reference

12 December 2020

AP-1 function and regulation

1 reference

12 December 2020

Programmed cell death in the absence of c-Fos and c-Jun

1 reference

12 December 2020

The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation

1 reference

12 December 2020

10.1007/S11010-006-9371-8

Identifiers

DOI

1 reference

18 September 2017

1 reference